We now have Quarter 4 H1B visa FY 2023 data and Quarter 4 PERM visa FY 2023 data and Quarter 4 H2A visa FY 2023 data.
Employer Search tool is moved to it's own page: "H1B Visa Data Search Tool"

Statistics and Summary

Chelsea Germak has been assisting clients through the H1B Visa process since 2022.

As of 2022, Chelsea Germak has succesfully submitted and recieved certification for 1,030 cases.

Chelsea Germak is located in Matawan, NJ, and has represented 56 employers for the H1B Visa Process

1,048
Cases Handled
1,030
Cases Certified
98.28%
Approval

Cases Handled by Chelsea Germak

Case Number Case Status Job Title Industry Name Employer Name Year
I-200-21098-209779 Certified Biological Technicians Research And Development In The Physical Engineering And Life Sciences Regeneron Pharmaceuticals Inc 2021
I-200-21098-208311 Certified Biological Technicians Research And Development In The Physical Engineering And Life Sciences Regeneron Pharmaceuticals Inc 2021
I-200-21083-171906 Certified Biological Technicians Research And Development In The Physical Engineering And Life Sciences Regeneron Pharmaceuticals Inc 2021
I-200-21068-133293 Certified Biological Technicians Research And Development In The Physical Engineering And Life Sciences Regeneron Pharmaceuticals Inc 2021
I-203-20219-755333 Certified Materials Scientists Petroleum Lubricating Oil And Grease Manufacturing Infineum Usa Inc 2020
I-200-20223-759153 Certified - Withdrawn Chemists Medical Laboratories Teva Pharmaceuticals Usa Inc 2021
I-200-23262-359094 Certified Chemists Research And Development In The Physical Engineering And Life Sciences Regeneron Pharmaceuticals Inc 2023
I-200-23125-996837 Certified Chemists Research And Development In The Physical Engineering And Life Sciences Regeneron Pharmaceuticals Inc 2023
I-200-23122-985609 Certified Chemists Research And Development In The Physical Engineering And Life Sciences Regeneron Pharmaceuticals Inc 2023
I-200-23117-972831 Certified Chemists Research And Development In The Physical Engineering And Life Sciences Regeneron Pharmaceuticals Inc 2023